Primary sources, clear limits
These are source starting points, accessed for the 1 November 2026 launch review. Regulations and pages can change. Read the current original source and use qualified review for a specific product or jurisdiction.
| Source | Why it is linked |
|---|---|
| NIH ODS — exercise and athletic performance | Background on evidence limits and the distinction between ingredient research and a finished formulation. |
| NIAAA — hangovers | Background for avoiding unsupported hangover-cure and accelerated alcohol-recovery promises. |
| FDA — dietary supplements | Official starting point for the United States supplement oversight context; not approval of these concepts. |
| European Commission — food supplements | Official starting point for EU supplement rules and ingredient-source review. |
| TGA — listed medicines | Official Australian pathway context where relevant to classification; not a declaration that the pathway applies. |
| UK Anti-Doping — managing supplement risks | Primary anti-doping guidance on supplement risk and the limitations of endorsement claims. |
| ZYN — mini and regular format comparison | Packaging geometry reference only; no affiliation, nicotine formulation transfer or brand endorsement. |
| VELO — slim format description | Comparative mini/slim format language only, not a universal size specification. |